2月26日 - ** 券商Stephens将家庭医疗服务提供商Addus HomeCare ADUS.O的目标价从153美元下调至142美元；维持 "增持 "评级
** 新的目标价较上一交易日收盘价有45.5%的上涨空间
** 券商称，联邦医疗保险计划Medicaid资金的不确定性推动该股走低，因为该公司的病人群体可能受到影响
** 该股周二收盘下跌 10.4%，年初至今已下跌约 22
** 不过，ADUS 认为，其在医疗补助计划内为老年人和残疾人提供低成本医疗服务的定位可能更能抵御更广泛的潜在削减。
** 周一收盘后，公司公布的季度利润为每小时 1.38 美元，而分析师预计为每小时 1.35 美元。
** 12家券商中有11家给予该股 "买入 "或同等评级，1家给予 "减持 "评级；他们的PT中值为138美元--数据由LSEG汇编
** 2024年ADUS上涨33.3
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.